Real-World Safety and Efficacy of Targeted Therapies in Rheumatoid Arthritis: A 5-Year, 5130-Case Follow-Up from FIRST Registry.

Rheumatol Ther · 2025 · PMC12084202 · PMID 40257743

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

Over the past 20 years, HAQ-DI scores at the initiation of b/tsDMARDs showed a decreasing trend in all age groups (Fig. 7 A).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.